ArticleLung cancer (Amsterdam, Netherlands)2022

Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer.

Daniel Sentana-Lledo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.